These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21935986)

  • 21. Crystal structure of the anti-(carcinoembryonic antigen) single-chain Fv antibody MFE-23 and a model for antigen binding based on intermolecular contacts.
    Boehm MK; Corper AL; Wan T; Sohi MK; Sutton BJ; Thornton JD; Keep PA; Chester KA; Begent RH; Perkins SJ
    Biochem J; 2000 Mar; 346 Pt 2(Pt 2):519-28. PubMed ID: 10677374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of an extended simulated annealing method: application to the modeling of complementary determining regions of immunoglobulins.
    Higo J; Collura V; Garnier J
    Biopolymers; 1992 Jan; 32(1):33-43. PubMed ID: 1617148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular modeling of antibody-combining sites.
    Webster DM; Rees AR
    Methods Mol Biol; 1995; 51():17-49. PubMed ID: 7581695
    [No Abstract]   [Full Text] [Related]  

  • 24. The third-dimensional structure of the complex between an Fv antibody fragment and an analogue of the main immunogenic region of the acetylcholine receptor: a combined two-dimensional NMR, homology, and molecular modeling approach.
    Kleinjung J; Petit MC; Orlewski P; Mamalaki A; Tzartos SJ; Tsikaris V; Sakarellos-Daitsiotis M; Sakarellos C; Marraud M; Cung MT
    Biopolymers; 2000 Feb; 53(2):113-28. PubMed ID: 10679615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ab initio structure prediction of the antibody hypervariable H3 loop.
    Zhu K; Day T
    Proteins; 2013 Jun; 81(6):1081-9. PubMed ID: 23255066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computer-assisted modeling of antibody variable domains.
    Ramos OH
    Methods Mol Biol; 2012; 907():39-55. PubMed ID: 22907344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The de novo design of an antibody combining site. Crystallographic analysis of the VL domain confirms the structural model.
    Essen LO; Skerra A
    J Mol Biol; 1994 Apr; 238(2):226-44. PubMed ID: 8158652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
    Kuroda D; Shirai H; Kobori M; Nakamura H
    Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure of antibody hypervariable loops reproduced by a conformational search algorithm.
    Bruccoleri RE; Haber E; Novotný J
    Nature; 1988 Oct; 335(6190):564-8. PubMed ID: 3419534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homology modeling of divergent proteins.
    Sudarsanam S; March CJ; Srinivasan S
    J Mol Biol; 1994 Aug; 241(2):143-9. PubMed ID: 8057355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular modeling study of the editing active site of Escherichia coli leucyl-tRNA synthetase: two amino acid binding sites in the editing domain.
    Lee KW; Briggs JM
    Proteins; 2004 Mar; 54(4):693-704. PubMed ID: 14997565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of an antibody model with an X-ray structure: the variable fragment of BR96.
    Bajorath J; Sheriff S
    Proteins; 1996 Feb; 24(2):152-7. PubMed ID: 8820482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody structure determination using a combination of homology modeling, energy-based refinement, and loop prediction.
    Zhu K; Day T; Warshaviak D; Murrett C; Friesner R; Pearlman D
    Proteins; 2014 Aug; 82(8):1646-55. PubMed ID: 24619874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization.
    Roberts VA; Stewart J; Benkovic SJ; Getzoff ED
    J Mol Biol; 1994 Jan; 235(3):1098-116. PubMed ID: 8289310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solution structure of an isolated antibody VL domain.
    Constantine KL; Friedrichs MS; Metzler WJ; Wittekind M; Hensley P; Mueller L
    J Mol Biol; 1994 Feb; 236(1):310-27. PubMed ID: 8107112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular modeling of an anti-DNA autoantibody (V-88) and mapping of its V region epitopes recognized by heterologous and autoimmune antibodies.
    Hobby P; Ward FJ; Denbury AN; Williams DG; Staines NA; Sutton BJ
    J Immunol; 1998 Sep; 161(6):2944-52. PubMed ID: 9743357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal structure of an antigen-binding fragment bound to single-stranded DNA.
    Tanner JJ; Komissarov AA; Deutscher SL
    J Mol Biol; 2001 Dec; 314(4):807-22. PubMed ID: 11733999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation, characterization and crystallization of an antibody Fab fragment that recognizes RNA. Crystal structures of native Fab and three Fab-mononucleotide complexes.
    Pokkuluri PR; Bouthillier F; Li Y; Kuderova A; Lee J; Cygler M
    J Mol Biol; 1994 Oct; 243(2):283-97. PubMed ID: 7523684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methods for the homology modeling of antibody variable regions.
    Sircar A
    Methods Mol Biol; 2012; 857():301-11. PubMed ID: 22323227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting antibody hypervariable loop conformations. II: Minimization and molecular dynamics studies of MCPC603 from many randomly generated loop conformations.
    Fine RM; Wang H; Shenkin PS; Yarmush DL; Levinthal C
    Proteins; 1986 Dec; 1(4):342-62. PubMed ID: 3449860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.